Decitabine-containing regimens could alleviate acute graft-versus-host disease via regulating intestinal epithelial-microbiota-innate lymphoid cells barrier
Published: 23 July 2026| Version 1 | DOI: 10.17632/7pjx5nys8r.1
Contributor:
Jinye ZhuDescription
A Bu/Cy-induced aGvHD mouse model was established in four groups (Non-DAC, DAC, BMT, Control). Post-conditioning, colon RNA/protein were analyzed by RT-qPCR (cytokines, tight junctions, mucins, ILC TFs) and CBA (cytokines); colonic ILC subsets were assessed by flow cytometry. On day +7, clinical scores, pathology, and CD3⁺ T-cell infiltration were evaluated, with repeated cytokine and ILC analyses. Additional aGvHD models (co-housed, pseudo-germ-free, differential colonization) were used for comparison; fecal metabolites were profiled to explore microbiota mechanisms via gut epithelial–microbiota–ILC crosstalk.
Files
Institutions
- Peking University First HospitalBeijing, Beijing
Categories
Medicine